![Melissa Tosca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 69 852 $ al 31/05/2026
Melissa Tosca is currently Chief Financial & Accounting Officer at Kiora Pharmaceuticals, Inc. since 2024.
Formerly, Ms. Tosca was Treasurer & Executive Director-Finance at Neomorph, Inc. Ms. Tosca completed undergraduate studies at the University of Arizona.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/07/2026 | 26.064 ( 0,59 % ) | 69 852 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/07/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Neomorph, Inc.
 Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Manufactures health drugs | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neomorph, Inc.
Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Manufactures health drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
